Dare Bioscience DARE
NASDAQ DARE
$0.81 +0.06 (+8.67%)
At close: Sep 29, 2026 · 4:00 PM EDT

Dare Bioscience (DARE) Acquisitions (2018 - 2019)

Updated

Dare Bioscience's Acquisitions came in at $6.14 million for Q4 2019, compared with -$507,000 a year earlier.

Analysis

Dare Bioscience (DARE) Acquisitions (2018 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -17.24 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -23.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.21 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Dare Bioscience 11.38 Mn -54.09 Mn -132,343.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 6.14 Mn
Dec 31, 2018 -507,000.00
Sep 30, 2018 55,000.00
API Access

Dare Bioscience Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=DARE&period=max&api_key=YOUR_API_KEY